Wolverine Trading, LLC Delcath Systems, Inc. Call Options Transaction History

Wolverine Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 18, 2025	SELL	$10.39 - $18.1 $36,365 - $63,350	-3,500 Reduced 10.51%	29,800 $405,000
Q1 2025 May 15, 2025	SELL	$11.43 - $16.45 $97,155 - $139,825	-8,500 Reduced 20.33%	33,300 $423,000
Q4 2024 Feb 14, 2025	BUY	$8.32 - $12.64 $347,776 - $528,352	41,800 New	41,800 $492,000
Q4 2023 Feb 14, 2024	BUY	$2.25 - $4.17 $22,500 - $41,700	10,000 New	10,000 $41,000

121

13.2M

105K

38.7K

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $95.4M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.